Scientists in drug discovery often spend excessive time managing research data instead of concentrating on identifying the most promising compounds for new drugs. The right technology streamlines the drug discovery process, providing a seamless workflow for data-driven design, analysis, and research tracking of small molecules.
In this webinar, experts from Certara and Chemaxon will guide scientists through the Design-Make-Test-Analyze (DMTA) cycle, demonstrating how D360 and Design Hub deliver the digital tools needed to:
- Analyze data from both real and virtual project compounds
- Formulate hypotheses and design candidate compounds
- Manage internal and external task assignment
- Monitor the progress of synthesis
This session is designed for research scientists, medicinal chemists, computational chemists, and discovery biologists looking to streamline their research processes. We look forward to welcoming you to this informative session, where advancing your research becomes our shared goal.